FDA Approved: JEMPERLI — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for JEMPERLI (dostarlimab) submitted by GlaxoSmithKline LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• JEMPERLI (DOSTARLIMAB)

Snippet

SUPPL AP for JEMPERLI (DOSTARLIMAB)